Phoenix, AZ (November 12, 2025) – A new AI platform is on the rise to redefine how physicians identify diseases at their earliest stages — even before symptoms appear.
Founded by and current CEO Dr. Azar Azad, A.I.VALI is ready to support physicians in diagnosing early-stage diseases that often go undetected. “Many of the earliest stages of disease are quiet, growing under the radar and harming patients. By combining AI with medical imaging, we can help physicians identify these conditions sooner and support better patient outcomes”, Dr. Azad said.
Making sure they stand out from everyone else A.I.VALI is healthcare-driven and focuses on technology that is not limited to one specialty with a team of physicians, AI scientists, and biomedical engineers who are all motivated to improve the quality of life for patients.“If we could use AI to quantitatively measure those changes, we could give physicians more powerful tools to help patients”, Dr. Azad said.
A.I.VALI is now working to expand the platform’s compatibility with other imaging modalities such as ultrasounds, MRI, and CT. This would allow clinicians to analyze multiple datasets in real time — a breakthrough for high-stress environments like emergency rooms and disaster response. “Imagine being able to process massive amounts of imaging data instantly during an emergency,” Dr. Azad said.
Another major goal of A.I.VALI is to make advanced diagnostic tools accessible in rural and underserved communities. “Many clinics lack the specialists or resources found in major hospitals. By democratizing technology like ours, we can bring top-tier diagnostic support directly to those communities,” Dr. Azad said.
In October, A.I.VALI had the opportunity to visit the PBC as a member of the XLR8 PBC F25 Cohort. They were able to network with a collaborative ecosystem connecting startups, academia, and healthcare institutions. “I was amazed by the infrastructure here. The way Phoenix brings together universities, clinical partners, and government support creates an ideal environment for innovation. Even as a Canadian company, we felt welcomed and supported at every step. It truly felt like heaven for startups,” Dr. Azad said.
About the Phoenix Bioscience Core
The Phoenix Bioscience Core (PBC) is a 30-acre life sciences innovation district located in downtown Phoenix. It hosts Arizona’s three public research universities—Arizona State University, Northern Arizona University, and the University of Arizona—as well as leading genomics pioneers like the Translational Genomics Research Institute (TGen), part of the City of Hope, and the International Genomics Consortium. The PBC also collaborates with major healthcare systems, including Banner Health, Phoenix Children’s Hospital, Dignity Health, HonorHealth, Phoenix VA, and Valleywise Health, alongside a growing number of emerging life science companies. This unique concentration of research scientists and healthcare professionals fosters unprecedented collaborations, advancing precision medicine from discovery to delivery. To learn more, please visit phoenixbiosciencecore.com
About XLR8 PBC
XLR8 PBC is a program for scale-ready companies seeking the capital, experience, and validation to move to the next level. Focusing on helping founders/CEO’s tell an investment story, find experienced executives, and sign partner deals that matter most to investors. Ideal applicants have a validated product or solution, early traction in the market, and are seeking strategic partnerships, mentorship, and investor connections to accelerate their growth. To learn more, please visit phoenixbiosciencecore.com/xlr8
By: Madisson Simental | November 12, 2025